Ore Robert M, Baldwin Lauren, Woolum Dylan, Elliott Erika, Wijers Christiaan, Chen Chieh-Yu, Miller Rachel W, DeSimone Christopher P, Ueland Frederick R, Kryscio Richard J, Nagell John R van, Pavlik Edward J
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky Chandler Medical Center-Markey Cancer Center, Lexington, KY 40536-0293, USA.
Department of Statistics, University of Kentucky Chandler Medical Center-Markey Cancer Center, Lexington, KY 40536-0293, USA.
Diagnostics (Basel). 2017 Mar 20;7(1):18. doi: 10.3390/diagnostics7010018.
To examine how frequently and confidently healthy women report symptoms during surveillance for ovarian cancer. A symptoms questionnaire was administered to 24,526 women over multiple visits accounting for 70,734 reports. A query of reported confidence was included as a confidence score (CS). Chi square, McNemars test, ANOVA and multivariate analyses were performed. 17,623 women completed the symptoms questionnaire more than one time and >9500 women completed it more than one four times for >43,000 serially completed questionnaires. Reporting ovarian cancer symptoms was ~245 higher than ovarian cancer incidence. The positive predictive value (0.073%) for identifying ovarian cancer based on symptoms alone would predict one malignancy for 1368 cases taken to surgery due to reported symptoms. Confidence on the first questionnaire (83.3%) decreased to 74% when more than five questionnaires were completed. Age-related decreases in confidence were significant (p < 0.0001). Women reporting at least one symptom expressed more confidence (41,984/52,379 = 80.2%) than women reporting no symptoms (11,882/18,355 = 64.7%), p < 0.0001. Confidence was unrelated to history of hormone replacement therapy or abnormal ultrasound findings (p = 0.30 and 0.89). The frequency of symptoms relevant to ovarian cancer was much higher than the occurrence of ovarian cancer. Approximately 80.1% of women expressed confidence in what they reported.
为了研究健康女性在卵巢癌监测期间报告症状的频率和自信程度。对24526名女性进行了多次访视,共收到70734份报告,发放了症状调查问卷。对报告的自信程度进行询问并作为自信评分(CS)。进行了卡方检验、麦克尼马尔检验、方差分析和多变量分析。17623名女性多次完成症状调查问卷,超过9500名女性完成问卷次数超过四次,累计完成问卷超过43000份。报告的卵巢癌症状比卵巢癌发病率高约245倍。仅基于症状识别卵巢癌的阳性预测值(0.073%)表明,因报告症状而接受手术的1368例病例中预计有1例为恶性肿瘤。首次问卷时的自信程度(83.3%)在完成五份以上问卷后降至74%。与年龄相关的自信程度下降具有显著性(p<0.0001)。报告至少一种症状的女性比未报告症状的女性表现出更高的自信程度(41984/52379 = 80.2% 对比 11882/18355 = 64.7%),p<0.0001。自信程度与激素替代疗法史或超声检查异常结果无关(p = 0.30和0.89)。与卵巢癌相关的症状出现频率远高于卵巢癌的实际发生率。约80.1%的女性对自己报告的内容表示自信。